Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New SREBP inhibitors identified at Capulus Therapeutics

Aug. 23, 2021

Sumitomo Dainippon Pharma Oncology patents serine/threonine kinase Nek2 inhibitors

Aug. 23, 2021

LP-184 induces tumor growth inhibition in glioblastoma models

Aug. 20, 2021

Well Marker Bio starts phase I study of WM-S1-030 for solid tumors

Aug. 19, 2021

TT-00420 enters phase I/II trial for advanced solid tumors

Aug. 19, 2021

Phenex Pharmaceuticals presents new AhR antagonists

Aug. 19, 2021

YAP/TEAD expression defines distinct vulnerabilities in binary pan-cancer groups

Aug. 19, 2021

Jiangsu Simcere Pharmaceutical presents BTK and JAK3 inhibitors

Aug. 18, 2021

Sichuan Kelun-Biotech Biopharmaceutical patents TGFR1 inhibitors

Aug. 18, 2021

IND application accepted for phase I/Ib trial for CPI-818 for treating R/R T-cell lymphoma in China

Aug. 17, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.